Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lena Pill"'
Autor:
Dominique Valteau-Couanet, Silke Kietz, Alberto Garaventa, Norbert Hosten, Penelope Brock, Stefanie Endres, Holger N. Lode, Emine Varol, Nikolai Siebert, Karoline Ehlert, Ruth Ladenstein, Hans Loibner, Lena Pill, Ina Mueller, Andreas Zinke, Evelyne Janzek, Winfried Barthlen
Publikováno v:
mAbs. 10:55-61
Immunotherapy with short term infusion (STI) of monoclonal anti-GD2 antibody (mAb) ch14.18 (4 × 25 mg/m2/d; 8–20 h) in combination with cytokines and 13-cis retinoic acid (RA) prolonged survival in...
Autor:
Ina, Mueller, Karoline, Ehlert, Stefanie, Endres, Lena, Pill, Nikolai, Siebert, Silke, Kietz, Penelope, Brock, Alberto, Garaventa, Dominique, Valteau-Couanet, Evelyne, Janzek, Norbert, Hosten, Andreas, Zinke, Winfried, Barthlen, Emine, Varol, Hans, Loibner, Ruth, Ladenstein, Holger N, Lode
Publikováno v:
mAbs
Immunotherapy with short term infusion (STI) of monoclonal anti-GD2 antibody (mAb) ch14.18 (4 × 25 mg/m2/d; 8–20 h) in combination with cytokines and 13-cis retinoic acid (RA) prolonged survival in high-risk neuroblastoma (NB) patients. Here, we i
Autor:
Karoline Ehlert, Christian Jensen, Diana Seidel, Alberto Garaventa, Evelyne Janzek, Ruth Ladenstein, Christin Eger, Juliet C. Gray, Lena Pill, Madlen Jüttner, Carla Manzitti, Silke Kietz, Isaac Yaniv, Hans Loibner, Ina Müller, Victoria Castel, Holger N. Lode, Nikolai Siebert, Dominique Valteau-Couanet, Stefanie Endres
Publikováno v:
Cancer Immunology Research. 4:A032-A032
Background: Ganglioside GD2 is a glycolipid highly expressed on neuro-ectodermal tumors including melanoma and neuroblastoma (NB). It is ranked on position 12 of the list of tumor associated antigens by the NCI. Anti-GD2 antibody (Ab) ch14.18/CHO tar
Autor:
Isaac Yaniv, Hans Loibner, Evelyne Janzek, Ina Mueller, Ruth Ladenstein, Christin Eger, Diana Seidel, Alberto Garaventa, Lena Pill, Christian Jensen, Stefanie Endres, Dominique Valteau-Couanet, Karoline Ehlert, Victoria Castel, Holger N. Lode, Nikolai Siebert, Silke Kietz, Juliet C. Gray, Madlen Juettner
Publikováno v:
Journal of Clinical Oncology. 33:TPS10080-TPS10080
TPS10080 Background: Long-term infusion (LTI) of anti-GD2 antibody ch14.18/CHO may improve outcome in patients (pts) with high risk relapsed/refractory neuroblastoma (NB). Methods: 97 pts received ...
Autor:
Christian Jensen, Silke Kietz, Penelope Brock, Holger N. Lode, Nikolai Siebert, Evelyne Janzek, Stefanie Endres, Hans Loibner, Karoline Ehlert, Ruth Ladenstein, Lena Pill, Ina Mueller, Dominique Valteau-Couanet
Publikováno v:
Journal of Clinical Oncology. 32:10028-10028
10028 Background: A less toxic treatment using long-term infusion (LTI) of anti-GD2antibody ch14.18/CHO and subcutaneous interleukin-2 (IL-2) may improve outcome in high risk neuroblastoma (NB). Me...